One of the mechanisms through which IL-17 contributes to the progression of SS is the induction of epithelial–mesenchymal transition (EMT) in glandular epithelial cells, which leads to fibrosis and functional tissue loss [121]. The gene discussed is IL17A; the disease is synovial sarcoma.